Carina Biotech Information

Get Verified Emails For Carina Biotech
Contact top employees from Carina Biotech

Summary

Carina Biotech

An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are...Show more

Organization Website

carinabiotech.com

Social Links

facebooklinkedIntwitter

Industries

Headquarters Location

Level 5, Catherine Helen Spence Building, UniSA City West Campus, Adelaide, South Australia, 5000 AU

Employees Size

1-10 employees

Specialties

CAR-T cells, immunotherapy, T cell biology, cancer biology, biomaterials, research & development, biotechnology, science

Founded

2016

Competitors

Founded
Type
Employees
Revenue
Funding
2015Privately
Held
1 - 25 < 1M $0
2015Privately
Held
1-10 - $-
2004Privately
Held
500-1000 - $-
2011- 1000-5000 - $-

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Carina Biotech shows a diverse range of experience levels:
9% have been with the company for less than 1 year9% for 1–2 years27% for 3–4 years27% for 5–7 years27% for 8–10 years
Discover More
Contact top employees from Carina Biotech

FAQ

Carina Biotech operates in the Biotech industries. More details can be found on the official website: carinabiotech.com.
The headquarters of Carina Biotech are located in Adelaide, Australia.
Carina Biotech currently employs 1-10 people.
Well-known competitors of Carina Biotech include Context Therapeutics, Leucadia Therapeutics, Advanced Therapies, LLC and Samsung Biologics.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP